Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes

• Published in: Journal of the American Society of Nephrology 2020-07, Vol.31 (7), p.1539-1554
• Main Authors: Cheng, Yuan, Wang, Dandan, Wang, Feng, Liu, Jing, Huang, Baorui, Baker, Maria Angeles, Yin, Jianyong, Wu, Rui, Liu, Xuanchen, Regner, Kevin R, Usa, Kristie, Liu, Yong, Zhang, Congxiao, Dong, Lijin, Geurts, Aron M, Wang, Niansong, Miller, Sheldon S, He, Yongcheng, Liang, Mingyu
• Format: Article
• Language: English
• Subjects: Adult; Albuminuria - genetics; Animals; Arteries - pathology; Basic Research; Blood Pressure - drug effects; Diabetic Nephropathies - metabolism; Diabetic Nephropathies - pathology; Female; Fibrosis; Gene Knockdown Techniques; Humans; Hypertension - complications; Hypertension - metabolism; Hypertension - physiopathology; Kidney - metabolism; Kidney - pathology; Male; Mice; Mice, Knockout; MicroRNAs - antagonists & inhibitors; MicroRNAs - genetics; MicroRNAs - metabolism; Middle Aged; Nephrosclerosis - etiology; Nephrosclerosis - metabolism; Nephrosclerosis - pathology; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics; Rats; Real-Time Polymerase Chain Reaction; Signal Transduction; Sodium Chloride, Dietary - administration & dosage; STAT3 Transcription Factor - metabolism; Up-Regulation
• ISSN: 1046-6673; 1533-3450
• DOI: 10.1681/ASN.2019101100

Aberrant microRNA (miRNA) expression affects biologic processes and downstream genes that are crucial to CKD initiation or progression. The miRNA miR-204-5p is highly expressed in the kidney but whether miR-204-5p plays any role in the development of chronic renal injury is unknown. We used real-time PCR to determine levels of miR-204 in human kidney biopsies and animal models. We generated knockout mice and used locked nucleic acid-modified anti-miR to knock down miR-204-5p in mice and rats. We used a number of physiologic, histologic, and molecular techniques to analyze the potential role of miR-204-5p in three models of renal injury. Kidneys of patients with hypertension, hypertensive nephrosclerosis, or diabetic nephropathy exhibited a significant decrease in miR-204-5p compared with controls. Dahl salt-sensitive rats displayed lower levels of renal miR-204-5p compared with partially protected congenic SS.13 rats. Administering anti-miR-204-5p to SS.13 rats exacerbated interlobular artery thickening and renal interstitial fibrosis. In a mouse model of hypertensive renal injury induced by uninephrectomy, angiotensin II, and a high-salt diet, gene knockout significantly exacerbated albuminuria, renal interstitial fibrosis, and interlobular artery thickening, despite attenuation of hypertension. In diabetic db/db mice, administering anti-miR-204-5p exacerbated albuminuria and cortical fibrosis without influencing blood glucose levels. In all three models, inhibiting miR-204-5p or deleting led to upregulation of protein tyrosine phosphatase SHP2, a target gene of miR-204-5p, and increased phosphorylation of signal transducer and activator of transcription 3, or STAT3, which is an injury-promoting effector of SHP2. These findings indicate that the highly expressed miR-204-5p plays a prominent role in safeguarding the kidneys against common causes of chronic renal injury.